Blistering, Papulosquamous, Connective Tissue and Alopecia. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Similar documents
CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASE. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP, AANP BOD, REGION 7

Difference Between Seborrheic Dermatitis and Psoriasis

An Approach to Common and not so Common Rashes in the Office FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

Otezla. Otezla (apremilast) Description

Psoriasis. Andrei Metelitsa, MD, FRCPC, FAAD Clinical Associate Professor, Dermatology, U of C Co-Director, Institute for Skin Advancement

Biologics for Autoimmune Diseases

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university

CIMZIA (certolizumab pegol)

Stelara. Stelara (ustekinumab) Description

Psoriasis. What is Psoriasis? What causes psoriasis? Medical Topics Psoriasis

S003 CPC Self-Assessment

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Dermatology GP Referral Guidelines

Cosentyx. Cosentyx (secukinumab) Description

Cimzia. Cimzia (certolizumab pegol) Description

PSORIASIS PSORIASIS. Anatomic sites FACTS ABOUT PROSIASIS PSORIASIS 11/16/2017 STIGMATA OF PSORIASIS

Facial Rash. Facial Rash 10/14/2013. Ten Look Alike Rashes Michelle DiBaise, MPAS, PA-C, DFAAPA Associate Clinical Professor NAU PA Program

Emergent and Urgent Dermatology, Eruptions, and Wound Care

Poonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital

Skin Deep: Cutaneous Lupus. Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

New Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

Regulatory Status FDA- approved indication: Simponi and Simponi ARIA are tumor necrosis factor (TNF) blockers indicated for the treatment of: (2-3)

1 P a g e. Systemic Juvenile Idiopathic Arthritis (SJIA) (1.3) Patients 2 years of age and older with active systemic juvenile idiopathic arthritis.

It is estimated that about 26,000 new cases of

Medication Policy Manual. Topic: Otezla, apremilast Date of Origin: May 9, 2014

Emergency Dermatology Dr Melissa Barkham

DESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S

Interesting Cases in Dermatology: Clinical Pearls for Primary Care Providers

Psoriasis: Causes, Symptoms, And Treatment

Psoriasis. Causes of Psoriasis

ACTEMRA (tocilizumab)

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Psoriatic Arthritis- Secondary Care

Xeljanz. Xeljanz, Xeljanz XR (tofacitinib) Description

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Table of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

A Patient s Guide to. Treatments for Psoriatic Arthritis

Dr Saleem Taibjee. Consultant Dermatologist & Dermatopathologist

Psoriasis. Jessica Kaffenberger, M.D. Assistant Professor of Dermatology Division of Dermatology The Ohio State University Wexner Medical Center

Some skin conditions

Psoriasis management. A/Prof Amanda Oakley Dermatologist, Waikato

Autoimmune Diseases with Oral Manifestations

Treatments used Topical including cleansers and moisturizer Oral medications:

Bacterial Infections in Pediatric Dermatology. Patrick McMahon, MD Children s Hospital of Philadelphia

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

Significance. Outline and Objectives. S007 Systemic Therapies for Medical Oncology

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.

Recognizing common Dermatologic conditions. Case presentations. CAPA 2015 Annual Conference. Tanya Nino, MD St. Joseph Heritage Medical Group

KEY MESSAGES. Psoriasis patients are more prone to cardiovascular diseases, stroke, lymphoma and non-melanoma skin cancers, and increased mortality.

Rashes Not To Be Missed In Children

PAPULOSQUAMOUS DISEASE AND VESICULOBULLOUS DISEASE

ERYTHRODERMA. ASAPA 2018 Fall Conference Tucson, AZ 10/12/2018. Andrew Newman, DO Pgy-3, Affiliated Dermatology/Honor Health

Tips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic

Regulatory Status FDA-approved indication: Orencia is a selective T cell co-stimulation modulator indicated for: (1)

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

If a drug trigger is suspected, stop the offending drug as this may reduce the risk of relapse.

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

OFF-LABEL USES IN DERMATOLOGY. Plaque psoriasis Initial dose of 80mg, followed by 40mg every other week (starting 1 week after initial dose)

Psoriatic Arthritis- Second Line Treatments

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Background AN UPDATED LOOK AT TREATMENTS FOR PLAQUE PSORIASIS JULY 2018 PLAQUE PSORIASIS TARGETED IMMUNOMODULATORS AS A TREATMENT OPTION

Psoriasis. and Biologic Treatments. Choose the best treatment to regain your quality of life. Edition 4

Malignant Cutaneous Neoplasms. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

A case of bullous pemphigoid following pemphigus foliaceus

Staying A- Head in Pediatric Dermatology:

Share your photos and diagnoses with us!

Pharmacy Management Drug Policy

Ask the Expert: Photosensitivity in Cutaneous Lupus

A48-year-old Hispanic woman

Topical Calcipotriol Algorithm

Another Rash? Managing Common Skin Problems in Primary Care: Ugh.Another Rash. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Recalcitrant Warty Erythroderma With Severe Pruritus. Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University

Dermatology Pearls. Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018

Inflammatory Dermatoses of the Vulva for the General/Gyn Pathologist with emphasis in the lichenoid pattern

Common Cutaneous Signs of Medical Illnesses

Dermclinic

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

Tips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter

An otherwise healthy 12-year-old

Rash Decisions Approach to the patient with a skin condition

Another Rash? Managing Common Skin Problems in Primary Care: Ugh.Another Rash. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

SELF-TEST QUESTIONNAIRE PSORIASIS. Plaque a raised lesion where the diameter is greater than the thickness. Number 2

A dash of dermatology and a pinch of rheumatology. Sarita Nori, MD, FAAD Dermatology Atrius Health

Conflicts of interest

Background information of DIF

GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

b) SKILLS The student should be able to

10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology

Transcription:

Blistering, Papulosquamous, Connective Tissue and Alopecia Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP

Objectives Identify examples of papulosquamous disease and state treatment options Identify examples of connective tissue disease and state treatment options Identify examples of blistering diseases and state treatment options Identify examples of alopecia and state treatment options

Papulosquamous

Psoriasis Latin means itchy plaque. In truth it is less itchy than yeast and eczema Variable Painful in high friction spots

Psoriasis Plaque kathleenhaycraft

Psoriasis kathleen haycraft

kathleenhaycraft

The clue to the vaginal pic kathleenhaycraft

kathleenhaycraft

Plantar Psoriasis kathleenhaycraft

Palmar Psoriasis kathleenhaycraft

Nivolumab induced Psoriasis kathleenhaycraft@yahoo.com

Psoriasis and its many forms Plaque..85% Scalp Palmoplantar Guttate Inverse Erythrodermic Psoriatic arthritis Psoriatic nails

Cause Affects 2 to 5% of the population Many mediators including the T cell lymphocyte. Many chemicals downstream including TNF alpha, PDE, Il 12, 23, 17 as well as a variety of inflammatory cytokines These chemicals are distributed throughout the body Imbalance between pro inflammatory and anti-inflammatory chemicals Can be triggered by strep, HIV, Hepatitis, and a wide variety of infectious organisms

Psoriasis causes Koebner phenomenon after surgery or trauma Drugs such as beta blockers, lithium, antimalarials The cytokines result in proliferation of keratinocytes and angiogenesis (resulting in the Auspitz sign) May be mild to severe and location of scalp, genitalia, face may trump degree of psoriasis (BSA-

Comorbidities Reviewed in the cutaneous manifestations of systemic disease Range from depression to MI, psoriatic arthritis, malignancy, Dm Future treatments may be based on how they treat the comorbids Diagnose with visual or biopsy

Treatment Topical corticosteroids..caution to not over use particularly in high risk areas. Vitamin D analogs eg. Vectical (calcitriol) and Dovonex (calcipotriene) Combination of above eg., Taclonex (combination of betamethasone and calcipotriene) in a solution or cream and Enstillar foam(also a combination of betamethasone and calcipotriene) more effective in foam. If thick scale use potent retinoid e.g, Tazarotene gel (Tazorac) Control itch if present Consider light box or sunlight

Systemic Treatments: Small molecules: MXT with folic acic Acitretin Apremilast (Otezla) Xeljanz (Tofacitinib)

Injectable TNF Alpha..Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept), Cimzia (certolizumab). IL12/23.. Stellara (ustekinumab) IL17..Seliq (Siliq), Cosentyx (secukinumab), Taltz (ixekizumab) IL 23.. Tremfya (guselkumab) There have been so many to keep up with Safer than the advertisers make you think Important to seek treatment for your patients

Seborrheic Dermatitis May occur on the face, scalp, ears, chest Occurs more frequently with Parkinson s, Downs, immune compromised and post stroke Lipophilic yeast Malessezia is increased in seb derm skin Diagnosis is visual and rarely requires biopsy If not responsive to routine therapy consider HIV Treat with topical azoles or selenium, may use orals to gain control for short term

Lichen Planus Have five qualities: pruritic, purple, planar (flat topped), polygonal, papules. Fine white lines called Wickham s striae Occur in genitalia, mouth and body TAC moist soaks, antihistamines and occasionally immune suppression

Lichen Planus kathleenhaycraft

Parapsoriasis Clinically may present like eczema and/or psoriasis Treatment follows either path

Parapsoriasis kathleenhaycraft@yahoo.com

Blistering Disease

Arthropod Bite Blisters kathleenhaycraft

Pemphigus Vulgaris Intraepidermal or cell to cell disease IGG desmogleins 1 and 3 May involve skin and all of mucous membranes through conjunctiva, mouth and entire GI system Positive Nikolsky and Absoe-Hansen sign Treatment Rituximab, mycophenylol, Imuran, Dapsone, IVIG,

My dentist told me I have lichen planus now my hair is falling out Kathleen haycraft

Pemphigus Vulgaris One of the blistering disease. We will discuss this afternoon Far more serious than bullous pemphigoid Softer blisters with positive Nikolksi and Absoe Hensen sign Imperative to refer fairly urgently. Treated with steroids (topical and oral), mycophenolol, niacin, cyclins High risk for infection. High risk for underlying illness. Rituximab (Rituxan)

Bullous Pemphigoid kathleen haycraft

Bullous Pemphigoid Blister formation occurs when hemidesmosomes (BP180 and 230) are targeted by autoantibodies Linked with Parkinsons, CVA, diuretics, antibiotics, neuroactive drugs and antihypertensives Because the bullae are deep the blisters are firm and difficult to rupture May have an urticarial phase only and never develop blisters\ Need ENT, Opthamology, GI referral Monitor the serum 180 and 230

Treatment Antihistamines Topical steroids Mycophenolol Niacin Doxycycline

Treatment Antihistamines Topical steroids Mycophenolol Niacin Doxycycline

Blistering Impetigo kathleenhaycraft

Treat the Impetigo Never treat without culture

My hands blister and I have blisters elsewhere. kathleenhaycraft

Another pic of the same kathleenhaycraft

Porphyria Cutanea Tarda Blistering rash frequently seen in hepatitis C patients. Patient had been treated for some time by PCP with steroids Hep C study positive for genotype type 1, after referral to hepatitis C treatment with Sovaldi (sofosbuvir). The treatment with sofosbuvir resulted complete remission of cutaneous symptoms Need workup for hemachromatosis and liver imaging Generally referral to liver specialist to be co-managed with dermatology and primary

Common Connective Tissue Disease

Livedo Reticularis kathleenhaycraft

Livedo Reticularis Lacy rash May be normal Ask about arthralgias

Lupus kathleenhaycraft

Lupus Erythematosus Assessment: erythematous patches on skin frequently on the malar area Always question if stiff in am Look for systemic involvement May be cutaneous alone and modest..genetics, female (10 times higher risk), smoking, infection Work up can be limited in primary care to ANA and UA Refer to rheumatology and dermatology Biopsies for all connective tissue disease are routine with a DIF

Treatment Plaquenyl (hydroxychloroquine sulfate) Immune Suppression Benlysta (belimumab) Short term topical and oral steroids

Have had this rash for a year been to dermatology and told it was lichen planus. kathleen haycraft

Diagnosis, Treatment Dermatomyositis Shawl sign, Gottron.s papules, violaceious hues on eyelids, capillary folds at nail beds Frequently rash flares with sun, fatigued with muscle pain Dependent upon different genetic mutations may have cancer or pulmonary and cardiac risk. This patient was treated with plaquenyl (hydroxychloroquine) sulfate

Morphea

Differentiating Routine Alopecia pearls Anagen effluvium Telogen effluvium non-scarring diffuse hair loss, normal scalp, last 1 to 6 months, affects less than 15% Catogen sudden and near 85% or total loss of hair with thin broken hair Trichotillomania irregular patches with variable hair growth Androgenic Male pattern, Christmas Tree Tinea Capitis round patches with broken hairs

Diagnostics Ferritin, TSH, thyroid antibodies, RPR Is suspect androgenic: free and total testosterone for females, DHEAS, prolactin If scalp is abnormal do punch biopsy with routine and DIF If infection suspected to tissue culture

Alopecia Aerata over PWS kathleenhaycraft

Alopecia Aerata kathleenhaycraft

Alopecia Aerata kathleenhaycraft

Dissecting Cellulitis vs Folliculitis Decalvens kathleen haycraft

Rash oozy and my hair is falling out. Kathleen Haycraft

Folliculitis Decalvens of Dissecting Cellulitis of the Scalp Scalp situations that must be referred immediately as early treatment with cyclins, and intralesional and topical steroids may prevent permanent scarring and hair loss. Oral cyclins and immune suppression may be used When a scalp is tender, erythematous and boggy REFER.do not wait

A little brain fog yet?

References: Bolognia, Jean L., Jorizzo, Josep L., & Shaffer, Julie V. (2012). Dermatology: 2- Volume Set: Expert Consult Premium Edition (3 rd ed). Philadelphia, PA: Saunders. DermNet NZ: the dermatology resource. (2016). Retrieved from http://www.dermnetnz.org/ Habif, Thomas B. (2015). Clinical Dermatology (5th ed.). Philadelphia, PA: Mosby. Medscape Reference: Drugs, Diseases, and Procedures. (2016). Retrieved from http://reference.medscape.com/ James, William D., Berge, Timothy, & Elston, D. (2015). Andrews' Diseases of the Skin, 11th Edition (11th ed.). Philadelphia, PA: Saunders. Cutis Journal Years 2016-2017 Bobonich & Nolen (2015). Dermatology for Advance Practice Clinicians. Philadelphia, PA; Wolthers Kluwer

Thank you. Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP 300 Lovers Leap Dr Hannibal, MO 63401 kathleenhaycraft@yahoo.com 5737952808